As the COVID-19 federal public health emergency and its subsequent pandemic restrictions are set to end in May 2023, the future of telemedicine prescribing has become a central question for many physicians and consumers.
D.C. Circuit Holds That Former Purdue Pharma Executives Who Pleaded Guilty to Misdemeanor Misbranding May Be Excluded From Participation in Federal Health Care Programs